FDA Approves First RSV Vaccine for Older Adults
On May 3, the Food and Drug Administration (FDA) approved the first respiratory syncytial virus (RSV) vaccine for use in the U.S. FDA approved the drug, Arexvy from GSK, for prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age or older. RSV is a highly contagious virus that is […]
